| 104.73 Delayed Data As of 4:02pm ET |  -1.09 / -1.03%Today’s Change | 78.95 Today|||52-Week Range 107.97 | +25.77% Year-to-Date |
| DGX vs. ADUS: Which Stock Is the Better Value Option? Sep 17 / Zacks.com - Paid Partner Content | Is Quest Diagnostics (DGX) a Great Value Stock Right Now? Sep 17 / Zacks.com - Paid Partner Content |
| Previous close | 105.82 |
| Today’s open | 105.89 |
| Day’s range | 104.61 - 106.23 |
| Volume | 1,068,991 |
| Average volume (3 months) | 883,332 |
| Market cap | $13.9B |
| Earnings growth (last year) | -3.97% |
| Earnings growth (this year) | +2.96% |
| Earnings growth (next 5 years) | +6.40% |
| Revenue growth (last year) | -2.31% |
| P/E ratio | 20.3 |
| Price/Sales | 1.54 |
| Price/Book | 2.68 |
| Today’s change | Today’s % change | |
|---|---|---|
| LHLaboratory Corporati... | +0.52 | +0.31% |
| GHGuardant Health Inc | +2.74 | +4.21% |
| GHDXGenomic Health Inc | -0.09 | -0.13% |
| NTRANatera Inc | +1.69 | +4.66% |
| Next reporting date | October 22, 2019 |
| EPS forecast (this quarter) | $1.71 |
| Annual revenue (last year) | $7.5B |
| Annual profit (last year) | $733.0M |
| Net profit margin | 9.73% |
Sector Health Services |
Industry Services to the Health Industry |
No executives to display |
Corporate headquarters Secaucus, New Jersey |
